Life Sciences Research for Lifelong Health

Charlene Fabian

Charlene was awarded an MSci in Molecular and Cellular Biology by the University of Glasgow in 2016. As part of her course, Charlene undertook a one-year research placement within the Refractory, Respiratory and Inflammation Discover Performance Unit of GSK, where she was involved in target identification.

Charlene started her PhD at the Babraham Institute in October 2016 and is funded by an MRC Industrial CASE Studentship. In collaboration with DefiniGEN, Charlene will investigate the role of epigenetic processes in the specification of pancreatic cells from human pluripotent stem cells.

Latest Publications

Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications.

Andrews PW, Ben-David U, Benvenisty N

Stem cell reports
9 2213-6711:1-4 (2017)

PMID: 28700896

Global reorganisation of cis-regulatory units upon lineage commitment of human embryonic stem cells.

Freire-Pritchett P, Schoenfelder S, Várnai C

eLife
6 2050-084X: (2017)

PMID: 28332981

Derivation and Culture of Epiblast Stem Cell (EpiSC) Lines.

Rugg-Gunn P

Cold Spring Harbor protocols
2017 1559-6095:pdb.prot093971 (2017)

PMID: 28049783

Derivation and Culture of Extra-Embryonic Endoderm Stem Cell Lines.

Rugg-Gunn P

Cold Spring Harbor protocols
2017 1559-6095:pdb.prot093963 (2017)

PMID: 28049782

Crosstalk between pluripotency factors and higher-order chromatin organization.

Lopes Novo C, Rugg-Gunn PJ

Nucleus (Austin, Tex.)
1949-1042:0 (2016)

PMID: 27759487

Comparative Principles of DNA Methylation Reprogramming during Human and Mouse In Vitro Primordial Germ Cell Specification.

von Meyenn F, Berrens RV, Andrews S

Developmental cell
39 1878-1551:104-115 (2016)

PMID: 27728778